TDX Share Price

Open 0.00 Change Price %
High 0.00 1 Day 0.00 0.00
Low 0.00 1 Week 0.00 0.00
Close 0.30 1 Month 0.00 0.00
Volume 100000 1 Year 0.30 0.00
52 Week High 0.00
52 Week Low 0.00
TDX Important Levels
Resistance 2 0.30
Resistance 1 0.30
Pivot 0.10
Support 1 0.30
Support 2 0.30
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TLS 4.82 0.00%
TLS 4.82 0.00%
TLS 4.82 0.00%
RXL 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IVT 0.02 100.00%
COY 0.02 100.00%
COY 0.02 100.00%
COY 0.02 100.00%
PMQ 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AYR 0.01 -50.00%
AYR 0.01 -50.00%
AYR 0.01 -50.00%
GDY 0.01 -50.00%
CMP 0.44 -34.33%
More..

Tyrian Diagnostics Ltd (ASX: TDX)

TDX Technical Analysis 5
As on 22nd Jun 2016 TDX Share Price closed @ 0.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.00 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
TDX Target for February
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
TDX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.tyriandx.com
TDX Address
TDX
167 Macquarie Street
Level 10
Sydney, NSW 2000
Australia
Phone: 61 2 9889 1830
Fax: 61 2 9889 1805
TDX Latest News
Contango Global Growth locks in brokers; Deutsche Bank's bonus pain looms   The Australian Financial Review   - 26th Feb 17
Qantas shares rally on results, but CEO says earnings volatility part of ...   CNBC   - 23rd Feb 17
Contango plans to launch listed investment firm   Money Management   - 10th Feb 17
BRIEF-Contango Asset Management announces intention to launch ASX listed ...   Reuters   - 09th Feb 17
Contango's Boubouras: Commodities May Rally in 2H   Bloomberg   - 13th Jan 17
Deutsche Bank to Settle US Mortgage Probe for $7.2 Billion   Bloomberg   - 23rd Dec 16
Contango Asset Management to step up Sydney presence   The Australian Financial Review   - 16th Nov 16
Contango grows team   Money Management   - 14th Sep 16
Contango AM announces management buyout   InvestorDaily   - 27th Jun 16
Tyrian Diagnostics Ltd in $13M buyout of Contango Asset Management   Proactive Investors Australia   - 24th Jun 16
Interactive Technical Analysis Chart Tyrian Diagnostics Ltd ( TDX ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Tyrian Diagnostics Ltd
TDX Business Profile
Tyrian Diagnostics Limited develops and commercializes diagnosis technologies. It discovers and validates biomarkers for tuberculosis; and develops DiagnostIQ, a proprietary point of care diagnostics platform. The company licenses its core intellectual property assets, including DiagnostIQ device, a small disposable plastic capsule for diagnostic testing; and TB biomarker patents. The company is headquartered in Sydney, Australia.